UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000018383
Receipt number R000021216
Scientific Title A Phase Ib study of Trastuzumab emtansine plus S-1 or Capecitabine in patients with previously trastuzumab treated metastatic breast cancer
Date of disclosure of the study information 2015/07/23
Last modified on 2018/01/23 14:04:28

No. Disposal Last modified on Item of update
1 Insert 2015/07/22 16:01:43
2 Update 2015/07/23 10:01:53 Acronym
Acronym
3 Update 2015/07/29 09:10:20 Basic design
Control
No. of arms
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
4 Update 2015/07/31 18:18:07 Basic design
Control
No. of arms
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
5 Update 2016/08/09 10:15:41 Division name
Division name
Name of primary person or sponsor
Organization
6 Update 2018/01/23 14:04:28 Recruitment status
Date of protocol fixation
Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded